Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.57p
   
  • Change Today:
    -0.020p
  • 52 Week High: 2.61
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 609,628
  • Market Cap: £6.54m
  • RiskGrade: 328
  • Beta: 0.70

Latest ShareCast News

ImmuPharma progresses P140 clinical programme with FDA

By Josh White

Date: Wednesday 12 Apr 2023

(Sharecast News) - Drug discovery and development company ImmuPharma announced positive progress in its late-stage P140 clinical programme on Tuesday, for patients with chronic idiopathic demyelinating polyneuropathy (CIDP), a rare neurological disease with high medical need.

ImmuPharma upbeat after meeting with US partner Avion

By Josh White

Date: Friday 11 Nov 2022

(Sharecast News) - Drug discovery and development specialist ImmuPharma updated the market on a recent meeting in Atlanta with its United States partner Avion Pharmaceuticals on Friday, for strategic discussions around its 'Lupuzor' clinical programme.

ImmuPharma's US partner receives FDA response on Lupuzor

By Josh White

Date: Wednesday 14 Sep 2022

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced on Wednesday that its US partner for 'Lupuzor', Avion Pharmaceuticals, has received a written response from the Food and Drug Administration (FDA).

ImmuPharma making final preparations for Lupuzor... 04-May-2022 ShareCast
ImmuPharma surges on success in latest trial of ... 13-Apr-2022 ShareCast
ImmuPharma updates plan for trials of lupus trea... 07-Feb-2022 ShareCast
ImmuPharma raises £3.55m to fund research pipeline 20-Dec-2021 ShareCast
ImmuPharma signs two-year collaboration deal wit... 29-Nov-2021 ShareCast
ImmuPharma reports 'significant' progress since ... 18-Nov-2021 ShareCast
FDA gives ImmuPharma go-ahead for pharmacokineti... 12-Aug-2021 ShareCast
ImmuPharma clarifies next steps for phase 3 Lupu... 09-Feb-2021 ShareCast
ImmuPharma gets December date for FDA meeting 20-Nov-2020 ShareCast
ImmuPharma confirms continued FDA delays for Lup... 11-Sep-2020 ShareCast
Immupharma raises £6.5m in oversubscribed placing 02-Sep-2020 ShareCast
ImmuPharma clears 'important' regulatory hurdle ... 27-Jul-2020 ShareCast
ImmuPharma shares surge on Covid-19 potential 14-May-2020 ShareCast
ImmuPharma raises ?1.5m to fund development prog... 30-Mar-2020 ShareCast
ImmuPharma and Avion to proceed with Lupuzor pha... 06-Feb-2020 ShareCast
ImmuPharma says not looking to raise funds 11-Dec-2019 ShareCast
ImmuPharma shares soar as it teams up with Avion... 28-Nov-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.57p
Change Today -0.020p
% Change -1.26 %
52 Week High 2.61
52 Week Low 0.85
Volume 609,628
Shares Issued 416.44m
Market Cap £6.54m
Beta 0.70
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.47% below the market average71.47% below the market average71.47% below the market average71.47% below the market average71.47% below the market average
28% below the sector average28% below the sector average28% below the sector average28% below the sector average28% below the sector average
Price Trend
51.45% below the market average51.45% below the market average51.45% below the market average51.45% below the market average51.45% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:35 21,199 @ 1.57p
16:35 18,466 @ 1.57p
16:35 2,733 @ 1.57p
16:04 27,602 @ 1.56p
11:56 25,000 @ 1.60p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page